Intensity Therapeutics, Inc.

As of April 23, 2025, the technical trend has shifted to bearish, supported by bearish MACD signals, moving averages, and Bollinger Bands, despite a bullish OBV on the monthly chart.

Intensity Therapeutics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $3 million and a market cap of $4.32 million. Key financial metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -1,501.20%.

As of Jun 18, Intensity Therapeutics, Inc. has a market capitalization of 4.32 million, with net sales of 0.00 million and a net profit of -15.01 million over the last four quarters. The company's shareholder's funds are 2.92 million, and total assets are 4.78 million.